Clinical trial
SB-705498 Dental Pain Study After Tooth Extraction
NCT00281684 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00281684 |
|---|---|
| Title | SB-705498 Dental Pain Study After Tooth Extraction |
| Official title | A Multi-centre, Randomised, Single Blind, Placebo Controlled, Parallel Group Study to Examine the Effect of Single Doses of SB-705498, a TRPV1 Receptor Antagonist, on Pain Following Third Molar Tooth Extraction |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Toothache |
| Intervention type | Drug |
| Interventions | SB705498 400 mg, SB705498 1000 mg, Placebo, Co-Codamol |
| Enrollment | 145 |
| Start date | Dec 7, 2005 |
| Primary completion | Oct 3, 2007 |
| Completion | Oct 3, 2007 |
| First posted | Jan 25, 2006 |
| Last update posted | Jan 28, 2019 |
| Countries | Italy, South Korea, United Kingdom |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: